|
Chlorine in PDB 7vre: The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892Enzymatic activity of The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892
All present enzymatic activity of The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892:
2.7.10.1; Protein crystallography data
The structure of The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892, PDB code: 7vre
was solved by
S.J.Zhu,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892
(pdb code 7vre). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892, PDB code: 7vre: Jump to Chlorine binding site number: 1; 2; Chlorine binding site 1 out of 2 in 7vreGo back to Chlorine Binding Sites List in 7vre
Chlorine binding site 1 out
of 2 in the The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892
Mono view Stereo pair view
Chlorine binding site 2 out of 2 in 7vreGo back to Chlorine Binding Sites List in 7vre
Chlorine binding site 2 out
of 2 in the The Crystal Structure of Egfr T790M/C797S with the Inhibitor HCD2892
Mono view Stereo pair view
Reference:
H.Chen,
M.Lai,
T.Zhang,
Y.Chen,
L.Tong,
S.Zhu,
Y.Zhou,
X.Ren,
J.Ding,
H.Xie,
X.Lu,
K.Ding.
Conformational Constrained 4-(1-Sulfonyl-3-Indol)Yl-2-Phenylaminopyrimidine Derivatives As New Fourth-Generation Epidermal Growth Factor Receptor Inhibitors Targeting T790M/C797S Mutations. J.Med.Chem. V. 65 6840 2022.
Page generated: Tue Apr 4 22:07:04 2023
ISSN: ISSN 0022-2623 PubMed: 35446588 DOI: 10.1021/ACS.JMEDCHEM.2C00168 |
Last articlesZn in 8WB0Zn in 8WAX Zn in 8WAU Zn in 8WAZ Zn in 8WAY Zn in 8WAV Zn in 8WAW Zn in 8WAT Zn in 8W7M Zn in 8WD3 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |